Catalyst
Slingshot members are tracking this event:
Amicus Therapeutics' (FOLD) SD-101 for rare skin blistering disorder earns rare pediatric disease designation from FDA
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| FOLD | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
May 31, 2017
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Rare Pediatric Disease Designation, Sd-101, Skin Blistering Disorder
